Skip to main content
. 2012 Apr 3;2012:263267. doi: 10.1155/2012/263267

Figure 5.

Figure 5

Synergistic epigenetic therapy enhances the taxol response of ovarian tumor cells. A547 cells were treated with carrier (DMSO) or a combination of RG108 and Zebularine (mix) for 48 hours, after which 400 nM Taxol was added and the cells incubated for an additional 48 hours. The number of viable cells was determined by trypan blue staining. Data are expressed as percent surviving cells relative to non-Taxol-treated cells for each condition.